Breast cancer screening, mammography, and other modalities
JV Fiorica - Clinical obstetrics and gynecology, 2016 - journals.lww.com
This article is an overview of the modalities available for breast cancer screening. The
modalities discussed include digital mammography, digital breast tomosynthesis, breast …
modalities discussed include digital mammography, digital breast tomosynthesis, breast …
[PDF][PDF] Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study
HJ Long III, BN Bundy, EC Grendys Jr… - Journal of clinical …, 2005 - academia.edu
Purpose On the basis of reported activity of methotrexate, vinblastine, doxorubicin, and
cisplatin (MVAC) or topotecan plus cisplatin in advanced cervix cancer, we undertook a …
cisplatin (MVAC) or topotecan plus cisplatin in advanced cervix cancer, we undertook a …
Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer
TM Gritsko, D Coppola, JE Paciga, L Yang, M Sun… - Clinical cancer …, 2003 - AACR
Previous studies have demonstrated amplification of the centrosome serine/threonine
kinase BTAK/Aurora-A in 10–25% of ovarian cancers. However, alterations of BTAK/Aurora …
kinase BTAK/Aurora-A in 10–25% of ovarian cancers. However, alterations of BTAK/Aurora …
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study
GF Fleming, MW Sill, KM Darcy, DS McMeekin… - Gynecologic …, 2010 - Elsevier
PURPOSE: This study evaluated efficacy of single-agent trastuzumab against advanced or
recurrent HER2-positive endometrial carcinoma (EC), and explored predictors for HER2 …
recurrent HER2-positive endometrial carcinoma (EC), and explored predictors for HER2 …
Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study
JV Fiorica, VL Brunetto, P Hanjani, SS Lentz… - Gynecologic …, 2004 - Elsevier
Objectives. To estimate the objective response rate and toxicity associated with alternating
megestrol acetate (MA) and tamoxifen citrate (T) in women with endometrial carcinoma …
megestrol acetate (MA) and tamoxifen citrate (T) in women with endometrial carcinoma …
Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651 …
H Hricak, C Gatsonis, DS Chi, MA Amendola… - Journal of clinical …, 2005 - ascopubs.org
Purpose To compare magnetic resonance imaging (MRI) and computed tomography (CT)
with each other and to International Federation of Gynecology and Obstetrics (FIGO) clinical …
with each other and to International Federation of Gynecology and Obstetrics (FIGO) clinical …
Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies.
ML Echt, MA Finan, MS Hoffman, RC Kline… - Southern medical …, 1999 - europepmc.org
Background Identification of sentinel lymph nodes may allow prediction of metastatic
disease in cancer patients. We did a prospective study to determine whether lymphazurin …
disease in cancer patients. We did a prospective study to determine whether lymphazurin …
Uterine junctional zone: correlation between histologic findings and MR imaging.
HK Brown, BS Stoll, SV Nicosia, JV Fiorica… - Radiology, 1991 - pubs.rsna.org
Uterine zonal anatomy as visualized on T2-weighted (repetition time, 2,500 msec; echo time,
80 msec) magnetic resonance (MR) images consists of a high-intensity central (endometrial) …
80 msec) magnetic resonance (MR) images consists of a high-intensity central (endometrial) …
A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer
SL Decesare, JV Fiorica, WS Roberts, D Reintgen… - Gynecologic …, 1997 - Elsevier
Objective. To identify sentinel lymph nodes using intraoperative lymphoscintigraphy.
Methods. Technetium-99-labeled sulfur colloid was injected at the site of primary vulvar …
Methods. Technetium-99-labeled sulfur colloid was injected at the site of primary vulvar …
Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival?
MA Finan, S DeCesare, JV Fiorica, R Chambers… - Gynecologic …, 1996 - Elsevier
Two hundred twenty-nine patients with Stage IB cervical cancer treated with radical
hysterectomy were assigned to the new FIGO substages IB1 (n= 181) and IB2 (n= 48) based …
hysterectomy were assigned to the new FIGO substages IB1 (n= 181) and IB2 (n= 48) based …